Company Description
Limitless X (OTC: VYBE) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.
VYBE stock has declined 32.0% over the past year. Shares last traded at $0.3100.
This page provides a comprehensive overview of VYBE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Limitless X (VYBE) stock last traded at $0.3100. Over the past 12 months, the stock has lost 32.0%.
Latest News
Limitless X has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include partnership. View all VYBE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
VYBE Company Profile & Sector Positioning
Limitless X (VYBE) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.